Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by high disease burden in some countries, as well as delays in reaching mortality targets due to the long natural history of disease progression to liver cirrhosis and hepatocellular carcinoma.
National Hepatitis C ODN Event 2023 - Slides
Download
On September 12th 2023, HCV Action held our latest annual National ODN Stakeholder Event. This event is HCV Action’s annual gathering of ODN representatives and the wider hepatitis C professional community, and is intended to be an opportunity to discuss progress towards elimination, showcase best practice and successful projects, and identify solutions to common challenges in reaching elimination.
